89 related articles for article (PubMed ID: 7915754)
1. Treating peripheral arterial occlusive disease: pentoxifylline vs exercise.
Ciuffetti G; Paltriccia R; Lombardini R; Lupattelli G; Pasqualini L; Mannarino E
Int Angiol; 1994 Mar; 13(1):33-9. PubMed ID: 7915754
[TBL] [Abstract][Full Text] [Related]
2. [Controlled vascular training in IIb peripheral arterial occlusive disease: additive effect of intravenous PGE1 versus intravenous pentoxifylline during training].
Scheffler P; de la Hamette D; Müller H
Vasa Suppl; 1991; 33():350-2. PubMed ID: 1788754
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
Schweiger H; Ortmeier CJ
Pharmatherapeutica; 1989; 5(5):298-304. PubMed ID: 2526340
[TBL] [Abstract][Full Text] [Related]
4. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Dtsch Med Wochenschr; 1987 May; 112(22):873-8. PubMed ID: 3556133
[TBL] [Abstract][Full Text] [Related]
5. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Incandela L; Bucci M; Geroulakos G; Ramaswami G; Vasdekis S; Agus G; Bavera P; Ippolito E
Angiology; 2002; 53 Suppl 1():S7-12. PubMed ID: 11865838
[TBL] [Abstract][Full Text] [Related]
6. [Effect of 24-day exercise therapy on induced thrombocyte aggregation in peripheral arterial occlusive disease in Fontaine stage II].
Siostrzonek P; Klieber M; Niessner H
Wien Klin Wochenschr; 1985 Jan; 97(2):76-83. PubMed ID: 3984343
[TBL] [Abstract][Full Text] [Related]
7. Free radical production in peripheral vascular disease. A risk for critical ischaemia?
Ciuffetti G; Mercuri M; Mannarino E; Ott C; Lombardini R; Pasqualini L; Lupattelli G; Santambrogio L
Int Angiol; 1991; 10(2):81-7. PubMed ID: 1861091
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
[TBL] [Abstract][Full Text] [Related]
9. [Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases].
Giansante C; Di Chiara A; Fiotti N; Mauri F; Sorrentino A; Spanghero M; Tomasin L; Calabrese S
Clin Ter; 1990 Sep; 134(5):301-5. PubMed ID: 2149312
[TBL] [Abstract][Full Text] [Related]
10. Influence of controlled vascular training on the pain free walking distance and plasmaviscosity in patients suffering from peripheral arterial occlusive disease.
Häfner HM; Jünger I; Geyer A; Jünger M; Strölin A
Clin Hemorheol Microcirc; 2009; 41(1):73-80. PubMed ID: 19136745
[TBL] [Abstract][Full Text] [Related]
11. [Peripheral arterial occlusive disease in old age: the role of leukocytes].
Ciuffetti G; Ott C; Mercuri M; Lombardini R; Lupattelli G; Mannarino E
Z Gerontol; 1990; 23(6):361-4. PubMed ID: 2291305
[TBL] [Abstract][Full Text] [Related]
12. Leucocyte-endothelial interactions in chronic critical limb ischaemia.
Ciuffetti G; Lombardini R; Pasqualini L; Vaudo G
Ann Ital Med Int; 1996; 11(3):170-4. PubMed ID: 8950845
[TBL] [Abstract][Full Text] [Related]
13. Success of an outpatient claudication group training program for patients with peripheral arterial occlusive disease (PAOD): the Tübingen model.
Klyscz T; Jünger M; Jünger I; Hahn M; Rassner G
Cent Eur J Public Health; 1997 Mar; 5(1):13-20. PubMed ID: 9150999
[TBL] [Abstract][Full Text] [Related]
14. Outpatient rehabilitation in patients with coronary artery and peripheral arterial occlusive disease.
Jeger RV; Rickenbacher P; Pfisterer ME; Hoffmann A
Arch Phys Med Rehabil; 2008 Apr; 89(4):618-21. PubMed ID: 18373990
[TBL] [Abstract][Full Text] [Related]
15. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies.
Sandri M; Adams V; Gielen S; Linke A; Lenk K; Kränkel N; Lenz D; Erbs S; Scheinert D; Mohr FW; Schuler G; Hambrecht R
Circulation; 2005 Jun; 111(25):3391-9. PubMed ID: 15956121
[TBL] [Abstract][Full Text] [Related]
16. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
[TBL] [Abstract][Full Text] [Related]
17. Intermittent claudication in diabetics: treatment with exercise and pentoxifylline--a 6-month, controlled, randomized trial.
Belcaro G; Nicolaides AN; Griffin M; De Sanctis MT; Cesarone MR; Incandela L; Ippolito E; Pomante P; Geroulakos G; Ramaswami G
Angiology; 2002; 53 Suppl 1():S39-43. PubMed ID: 11865835
[TBL] [Abstract][Full Text] [Related]
18. Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training.
Scheffler P; de la Hamette D; Gross J; Mueller H; Schieffer H
Circulation; 1994 Aug; 90(2):818-22. PubMed ID: 8044953
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline therapy for chronic claudication: are patients dependent on therapy?
Johnson WC; Watkins MT; Hamilton J; Baldwin D; Walker N
Surgery; 1994 Jun; 115(6):735-9. PubMed ID: 8197567
[TBL] [Abstract][Full Text] [Related]
20. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
